These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 3166366

  • 1. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
    Ohuchi N, Matoba N, Taira Y, Takahashi K, Sakai N, Sato K, Fujita N, Mochizuki F, Nishihira T, Mori S.
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2767-72. PubMed ID: 3166366
    [Abstract] [Full Text] [Related]

  • 2. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
    Ohuchi N, Takahashi K, Matoba N, Sato T, Taira Y, Sakai N, Masuda M, Mori S.
    Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
    [Abstract] [Full Text] [Related]

  • 3. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
    Gang Y, Adachi I, Ohkura H, Yamamoto H, Mizuguchi Y, Abe K.
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
    [Abstract] [Full Text] [Related]

  • 4. [A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4].
    Ohuchi N, Takahashi K, Matoba N, Mori S.
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2761-6. PubMed ID: 2458074
    [Abstract] [Full Text] [Related]

  • 5. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR, Koda JE, Gaur PK.
    Cancer Res; 1987 Nov 15; 47(22):5853-60. PubMed ID: 2444335
    [Abstract] [Full Text] [Related]

  • 6. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.
    Cancer Res; 2001 Mar 15; 61(6):2523-32. PubMed ID: 11289125
    [Abstract] [Full Text] [Related]

  • 7. Significance of CA72.4 in patients with colorectal cancer. Comparison with CEA and CA19.9.
    Filella X, Molina R, Mengual PJ, Jo J, Ballesta AM.
    J Nucl Biol Med (1991); 1991 Mar 15; 35(3):158-61. PubMed ID: 1816871
    [Abstract] [Full Text] [Related]

  • 8. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
    Guadagni F, Roselli M, Amato T, Cosimelli M, Perri P, Casale V, Carlini M, Santoro E, Cavaliere R, Greiner JW.
    Cancer Res; 1992 Mar 01; 52(5):1222-7. PubMed ID: 1737383
    [Abstract] [Full Text] [Related]

  • 9. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.
    Kodama I, Koufuji K, Kawabata S, Tetsu S, Tsuji Y, Takeda J, Kakegawa T.
    Int Surg; 1995 Mar 01; 80(1):45-8. PubMed ID: 7657491
    [Abstract] [Full Text] [Related]

  • 10. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H, Teshima K, Noda K.
    Gan To Kagaku Ryoho; 1984 Dec 01; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [Abstract] [Full Text] [Related]

  • 11. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M, Hippeläinen M, Kettunen J, Salmela E, Penttilä I, Alhava E.
    Anticancer Res; 1994 Dec 01; 14(2B):699-703. PubMed ID: 8010729
    [Abstract] [Full Text] [Related]

  • 12. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y, Iwabuchi H, Sakunaga H, Sakamoto M, Okabe K, Sato H, Asano G.
    Gynecol Oncol; 1993 Feb 01; 48(2):148-54. PubMed ID: 8381375
    [Abstract] [Full Text] [Related]

  • 13. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
    Guadagni F, Roselli M, Cosimelli M, Spila A, Cavaliere F, Tedesco M, Arcuri R, Abbolito MR, Casale V, Pericoli MN, Vecchione A, Casciani CU, Greiner JW, Schlom J.
    Cancer Res; 1996 Nov 15; 56(22):5293-8. PubMed ID: 8912871
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of TAG-72 as a serum marker in ovarian and breast carcinoma.
    Esposito G, Panza N, Mansi L, De Matteis A, D'Aiuto G, Labonia V, Riccardi F, Pacilio G, Salvatore M.
    J Nucl Med Allied Sci; 1990 Nov 15; 34(2):88-93. PubMed ID: 2246676
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer].
    Ubukata H, Katano M, Motohashi G, Kasuga T, Takemura A, Tabuchi T, Tabuchi T.
    Gan To Kagaku Ryoho; 2003 Oct 15; 30(11):1821-4. PubMed ID: 14619529
    [Abstract] [Full Text] [Related]

  • 16. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
    Satake K, Chung YS, Umeyama K, Takeuchi T, Kim YS.
    Gan To Kagaku Ryoho; 1989 Apr 15; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
    [Abstract] [Full Text] [Related]

  • 17. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.
    Anticancer Res; 2000 Apr 15; 20(6D):5195-8. PubMed ID: 11326694
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical evaluation of the new tumor marker TAG-72.
    Guadagni F, Roselli M, Ferroni P, Amato T, Colcher D, Greiner JW, Schlom J.
    Anticancer Res; 1991 Apr 15; 11(4):1389-94. PubMed ID: 1746895
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
    Fujino N, Haga Y, Sakamoto K, Egami H, Kimura M, Nishimura R, Akagi M.
    Jpn J Clin Oncol; 1986 Dec 15; 16(4):335-46. PubMed ID: 3467106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.